BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $85

Benzinga · 2d ago
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $90 to $85.